Introduction Performance status (PS) is a standard functional classification in oncology
research and practice. However, despite its widespread use, little is known about the …

Purpose: Performance status is prognostic in oncology and palliative care settings.
Traditionally clinician rated, it is often inconsistently collected, recorded, and measured …

Introduction The Eastern Cooperative Oncology Group (ECOG) score is a well known
prognostic factor and almost always used to determine eligibility for clinical trials. The patient …

BACKGROUND: Performance status (PS) is a commonly used factor in determining the
appropriateness for chemotherapy of patients with non-small cell lung cancer (NSCLC). The …

Background: Studies have reported that performance status (PS) is a good prognostic
indicator in patients with advanced cancer. However, different health care professionals …

Oncologists traditionally assess their patients' ECOG performance status (PS), and few
studies have evaluated the accuracy of these assessments. In this study, 101 patients …

The quality of life of lung cancer patients is affected by several factors related to the patients,
stage of disease and treatment characteristics. For small-cell lung cancer (SCLC), the …

Purpose The process of assessing patient symptoms and functionality using patient-reported
outcomes (PROs) and functional performance status (FPS) is an essential aspect of patient …

What Is Patient PS? Patient PS is one of the most central factors in cancer care. It plays a
role both in shaping prognosis and in determining the best treatment for a patient with …

As cure is attainable in very few cases of lung cancer, the imperative issue is to make quality
of life (QOL) as good as possible as part of the palliative care package. The aim of this paper …